FeesSafety
Pluang+

Grant Cardone bets $1M Bitcoin will hit $126,210 by 2028, challenging Jason Calacanis' bearish view.

Market News
29 Oct 2026, 15:03 WIB
The Currency Analytics
View Source
Neutral
Grant Cardone bets $1M Bitcoin will hit $126,210 by 2028, challenging Jason Calacanis' bearish view.

Real estate investor Grant Cardone proposed a $1 million wager that Bitcoin will reach at least $126,210.50 by October 28, 2028, countering venture capitalist Jason Calacanis' prediction that Bitcoin won't surpass its previous all-time high. Calacanis cited weakening demand and suggested investors focus on AI instead. Cardone's challenge has drawn support from other Bitcoin advocates, highlighting ongoing debate about Bitcoin's future. Meanwhile, investment manager Bitwise projects Bitcoin could reach $1.6 million by 2036, reflecting optimism amid risks like regulation and technology disruption. No formal agreement on the wager has been made yet.

Bitcoin wager challenge offers context for cryptocurrency markets. For readers following crypto, here is Pluang's market snapshot as of Oct 29, 2026 18:53 WIB: Out of 50 major cryptocurrencies, 7 rose and 42 fell today. Bitcoin Cash (BCH) dropped 5.73% to Rp5.110.888 with a typical hold time of 69 days and order activity showing 42% sell and 58% buy. Axie Infinity (AXS) fell 4.31% to Rp16.838 with 99% sell orders. Kusama (KSM) declined 3.94% to Rp67.269, with 87% sell orders and a typical hold time of 80 days.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App